Yellow Fever Pipeline Review, H2 2012 New Report
Yellow Fever - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Yellow Fever, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Yellow Fever.
View full press release